Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

Sky Labs' CART-I ring – described as a cardio tracker – achieved 84.6% sensitivity compared to 69.1% for the Apple Watch, ...

The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies for rare and common diseases. With momentum building from ...

This July, the 13 th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

CSL Behring has added another major European market to the list of those providing reimbursement coverage of its haemophilia B gene therapy Hemgenix, after agreeing an access deal in Germany.

Reducing levels of LDL-cholesterol can reduce the risk of dementia by 26%, according to a new study, which also suggests statin drugs could provide an additional protective effect. The ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...